{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,25]],"date-time":"2026-01-25T01:23:55Z","timestamp":1769304235946,"version":"3.49.0"},"reference-count":86,"publisher":"Elsevier","isbn-type":[{"value":"9780128200766","type":"print"}],"license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020]]},"DOI":"10.1016\/bs.irn.2020.03.014","type":"book-chapter","created":{"date-parts":[[2020,7,10]],"date-time":"2020-07-10T08:25:09Z","timestamp":1594369509000},"page":"51-77","source":"Crossref","is-referenced-by-count":10,"title":["Tracking the potential involvement of metabolic disease in Alzheimer's disease\u2014Biomarkers and beyond"],"prefix":"10.1016","member":"78","reference":[{"issue":"13","key":"10.1016\/bs.irn.2020.03.014_bb0010","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1212\/WNL.0b013e3181f4d7f8","article-title":"Diabetes, Alzheimer disease, and vascular dementia: A population-based neuropathologic study","volume":"75","author":"Ahtiluoto","year":"2010","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/bs.irn.2020.03.014_bb0015","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/j.1365-2990.2008.00948.x","article-title":"Beta-amyloid deposition in brains of subjects with diabetes","volume":"35","author":"Alafuzoff","year":"2009","journal-title":"Neuropathology and Applied Neurobiology"},{"issue":"5","key":"10.1016\/bs.irn.2020.03.014_bb0020","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1176\/appi.ajp.159.5.738","article-title":"Longitudinal PET evaluation of cerebral metabolic decline in dementia: A potential outcome measure in Alzheimer's disease treatment studies","volume":"159","author":"Alexander","year":"2002","journal-title":"American Journal of Psychiatry"},{"issue":"1","key":"10.1016\/bs.irn.2020.03.014_bb0025","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.bcp.2013.08.026","article-title":"Biomarkers in pharmacology and drug discovery","volume":"87","author":"Anderson","year":"2014","journal-title":"Biochemical Pharmacology"},{"key":"10.1016\/bs.irn.2020.03.014_bb0030","first-page":"98","article-title":"Update on ultrasensitive technologies to facilitate research on blood biomarkers for central nervous system disorders","volume":"3","author":"Andreasson","year":"2016","journal-title":"Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring"},{"issue":"11","key":"10.1016\/bs.irn.2020.03.014_bb0035","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1212\/01.wnl.0000247053.45483.4e","article-title":"Diabetes is related to cerebral infarction but not to AD pathology in older persons","volume":"67","author":"Arvanitakis","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/bs.irn.2020.03.014_bb0040","doi-asserted-by":"crossref","first-page":"236","DOI":"10.3389\/fneur.2015.00236","article-title":"Blood-based proteomic biomarkers of Alzheimer's disease pathology","volume":"6","author":"Baird","year":"2015","journal-title":"Frontiers in Neurology"},{"key":"10.1016\/bs.irn.2020.03.014_bb0045","first-page":"619","article-title":"Sets of coregulated serum lipids are associated with Alzheimer's disease pathophysiology","volume":"11","author":"Barupal","year":"2019","journal-title":"Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring"},{"issue":"4","key":"10.1016\/bs.irn.2020.03.014_bb0050","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1093\/gerona\/60.4.471","article-title":"Type 2 diabetes is negatively associated with Alzheimer's disease neuropathology","volume":"60","author":"Beeri","year":"2005","journal-title":"The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences"},{"issue":"3","key":"10.1016\/bs.irn.2020.03.014_bb0055","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S2213-8587(13)70088-3","article-title":"Dementia and cognitive decline in type 2 diabetes and prediabetic stages: Towards targeted interventions","volume":"2","author":"Biessels","year":"2014","journal-title":"The Lancet Diabetes and Endocrinology"},{"issue":"4","key":"10.1016\/bs.irn.2020.03.014_bb0060","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00308809","article-title":"Neuropathological stageing of Alzheimer-related changes","volume":"82","author":"Braak","year":"1991","journal-title":"Acta Neuropathologica"},{"issue":"9","key":"10.1016\/bs.irn.2020.03.014_bb0065","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1001\/jamaneurol.2019.1534","article-title":"Diagnostic value of cerebrospinal fluid neurofilament light protein in neurology: A systematic review and meta-analysis","volume":"76","author":"Bridel","year":"2019","journal-title":"JAMA Neurology"},{"key":"10.1016\/bs.irn.2020.03.014_bb0070","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.mcn.2018.12.004","article-title":"Fluid and PET biomarkers for amyloid pathology in Alzheimer's disease","volume":"97","author":"Cohen","year":"2019","journal-title":"Molecular and Cellular Neuroscience"},{"issue":"12","key":"10.1016\/bs.irn.2020.03.014_bb0075","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/j.jalz.2016.06.001","article-title":"Levels of tau protein in plasma are associated with neurodegeneration and cognitive function in a population based elderly cohort","volume":"12","author":"Dage","year":"2016","journal-title":"Alzheimers Dement"},{"issue":"6","key":"10.1016\/bs.irn.2020.03.014_bb0080","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/S1474-4422(14)70090-0","article-title":"Advancing research diagnostic criteria for Alzheimer's disease: The IWG-2 criteria","volume":"13","author":"Dubois","year":"2014","journal-title":"The Lancet. Neurology"},{"issue":"13","key":"10.1016\/bs.irn.2020.03.014_bb0085","doi-asserted-by":"crossref","first-page":"e1150","DOI":"10.1212\/WNL.0000000000005214","article-title":"Midlife insulin resistance, APOE genotype, and late-life brain amyloid accumulation","volume":"90","author":"Ekblad","year":"2018","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/bs.irn.2020.03.014_bb0090","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nrneurol.2009.215","article-title":"The clinical use of structural MRI in Alzheimer disease","volume":"6","author":"Frisoni","year":"2010","journal-title":"Nature Reviews. Neurology"},{"key":"10.1016\/bs.irn.2020.03.014_bb0095","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ebiom.2015.11.036","article-title":"Plasma concentration of the neurofilament light protein (NFL) is a biomarker of CNS injury in HIV infection: A cross-sectional study","volume":"3","author":"Gissl\u00e9n","year":"2016","journal-title":"eBioMedicine"},{"issue":"2","key":"10.1016\/bs.irn.2020.03.014_bb0100","doi-asserted-by":"crossref","first-page":"629","DOI":"10.3233\/JAD-180297","article-title":"Metabolic syndrome and amyloid accumulation in the aging brain","volume":"65","author":"Gomez","year":"2018","journal-title":"Journal of Alzheimer's Disease"},{"issue":"14","key":"10.1016\/bs.irn.2020.03.014_bb0105","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1001\/jama.2017.3090","article-title":"Association between midlife vascular risk factors and estimated brain amyloid deposition","volume":"317","author":"Gottesman","year":"2017","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/bs.irn.2020.03.014_bb0110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0021643","article-title":"Metabolomics in early Alzheimer's disease: Identification of altered plasma sphingolipidome using shotgun lipidomics","volume":"6","author":"Han","year":"2011","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/bs.irn.2020.03.014_bb0115","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13195-019-0485-0","article-title":"Advantages and disadvantages of the use of the CSF amyloid \u03b2 (A\u03b2) 42\/40 ratio in the diagnosis of Alzheimer's disease","volume":"11","author":"Hansson","year":"2019","journal-title":"Alzheimer's Research & Therapy"},{"issue":"2","key":"10.1016\/bs.irn.2020.03.014_bb0120","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/ana.1054","article-title":"Large-scale, multicenter study of cerebrospinal fluid tau protein phosphorylated at serine 199 for the antemortem diagnosis of Alzheimer's disease","volume":"50","author":"Itoh","year":"2001","journal-title":"Annals of Neurology"},{"issue":"4","key":"10.1016\/bs.irn.2020.03.014_bb0125","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA-AA research framework: Toward a biological definition of Alzheimer's disease","volume":"14","author":"Jack","year":"2018","journal-title":"Alzheimer's Dementia"},{"issue":"2","key":"10.1016\/bs.irn.2020.03.014_bb0130","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S1474-4422(12)70291-0","article-title":"Tracking pathophysiological processes in Alzheimer's disease: An updated hypothetical model of dynamic biomarkers","volume":"12","author":"Jack","year":"2013","journal-title":"Lancet Neurology"},{"issue":"1","key":"10.1016\/bs.irn.2020.03.014_bb0135","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S1474-4422(09)70299-6","article-title":"Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade","volume":"9","author":"Jack","year":"2010","journal-title":"Lancet Neurology"},{"key":"10.1016\/bs.irn.2020.03.014_bb0140","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3389\/fneur.2015.00038","article-title":"PET imaging of tau pathology in Alzheimer's disease and tauopathies","volume":"6","author":"James","year":"2015","journal-title":"Frontiers in Neurology"},{"issue":"11","key":"10.1016\/bs.irn.2020.03.014_bb0145","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.1093\/brain\/aww224","article-title":"TDP-43 stage, mixed pathologies, and clinical Alzheimer's-type dementia","volume":"139","author":"James","year":"2016","journal-title":"Brain: A Journal of Neurology"},{"issue":"3","key":"10.1016\/bs.irn.2020.03.014_bb0150","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/s41591-020-0755-1","article-title":"Plasma P-tau181 in Alzheimer's disease: Relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer's dementia","volume":"26","author":"Janelidze","year":"2020","journal-title":"Nature Medicine"},{"issue":"7","key":"10.1016\/bs.irn.2020.03.014_bb0155","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.2967\/jnumed.113.127068","article-title":"Update on appropriate use criteria for amyloid PET imaging: Dementia experts, mild cognitive impairment, and education","volume":"54","author":"Johnson","year":"2013","journal-title":"Journal of Nuclear Medicine"},{"issue":"1","key":"10.1016\/bs.irn.2020.03.014_bb0160","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/npp.2008.174","article-title":"Metabolomics: A global biochemical approach to the study of central nervous system diseases","volume":"34","author":"Kaddurah-Daouk","year":"2008","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"10.1016\/bs.irn.2020.03.014_bb0165","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.jalz.2010.06.001","article-title":"Metabolomic changes in autopsy confirmed Alzheimer's disease","volume":"7","author":"Kaddurah-Daouk","year":"2011","journal-title":"Alzheimer's Dementia"},{"key":"10.1016\/bs.irn.2020.03.014_bb0170","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2013.18","article-title":"Alterations in metabolic pathways and networks in Alzheimer's disease","volume":"3","author":"Kaddurah-Daouk","year":"2013","journal-title":"Translational Psychiatry"},{"issue":"10","key":"10.1016\/bs.irn.2020.03.014_bb0175","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/s41582-018-0058-z","article-title":"Neurofilaments as biomarkers in neurological disorders","volume":"14","author":"Khalil","year":"2018","journal-title":"Nature Reviews. Neurology"},{"issue":"4","key":"10.1016\/bs.irn.2020.03.014_bb0180","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.3233\/JAD-2010-1332","article-title":"A relationship between Alzheimer's disease and type 2 diabetes mellitus through the measurement of serum amyloid-beta autoantibodies","volume":"19","author":"Kim","year":"2010","journal-title":"Journal of Alzheimer's Disease"},{"issue":"1","key":"10.1016\/bs.irn.2020.03.014_bb0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jalz.2014.07.003","article-title":"The Centiloid Project: Standardizing quantitative amyloid plaque estimation by PET","volume":"11","author":"Klunk","year":"2015","journal-title":"Alzheimer's Dementia"},{"issue":"5","key":"10.1016\/bs.irn.2020.03.014_bb0190","doi-asserted-by":"crossref","DOI":"10.1242\/dmm.031781","article-title":"Molecular biomarkers of Alzheimer's disease: Progress and prospects","volume":"11","author":"Lashley","year":"2018","journal-title":"Disease Models & Mechanisms"},{"issue":"1","key":"10.1016\/bs.irn.2020.03.014_bb0195","doi-asserted-by":"crossref","first-page":"9766","DOI":"10.1038\/s41598-017-09577-4","article-title":"Insulin resistance is associated with reductions in specific cognitive domains and increases in CSF tau in cognitively normal adults","volume":"7","author":"Laws","year":"2017","journal-title":"Scientific Reports"},{"issue":"2","key":"10.1016\/bs.irn.2020.03.014_bb0200","doi-asserted-by":"crossref","first-page":"813","DOI":"10.3233\/JAD-160722","article-title":"Cerebrospinal fluid A\u03b242\/40 corresponds better than A\u03b242 to amyloid PET in Alzheimer's disease","volume":"55","author":"Lewczuk","year":"2017","journal-title":"Journal of Alzheimer's Disease: JAD"},{"key":"10.1016\/bs.irn.2020.03.014_bb0205","first-page":"94","article-title":"Type 2 diabetes mellitus and cerebrospinal fluid Alzheimer's disease biomarker amyloid beta1-42 in Alzheimer's disease neuroimaging initiative participants","volume":"10","author":"Li","year":"2018","journal-title":"Alzheimer's & Dementia"},{"issue":"9","key":"10.1016\/bs.irn.2020.03.014_bb0210","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1212\/WNL.0b013e3181eee287","article-title":"Insulin resistance, type 2 diabetes, and AD: Cerebrovascular disease or neurodegeneration?","volume":"75","author":"Luchsinger","year":"2010","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/bs.irn.2020.03.014_bb0215","first-page":"15","article-title":"Adiposity and Alzheimer's disease","volume":"12","author":"Luchsinger","year":"2009","journal-title":"Current Opinion in Clinical Nutrition and Metabolic Care"},{"issue":"194","key":"10.1016\/bs.irn.2020.03.014_bb0220","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3006446","article-title":"Changes in amyloid-\u03b2 and tau in the cerebrospinal fluid of transgenic mice overexpressing amyloid precursor protein","volume":"5","author":"Maia","year":"2013","journal-title":"Science Translational Medicine"},{"key":"10.1016\/bs.irn.2020.03.014_bb0225","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1212\/WNL.0b013e3181eee25f","article-title":"Insulin resistance is associated with the pathology of Alzheimer's disease: The Hisayama study","volume":"75","author":"Matsuzaki","year":"2010","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/bs.irn.2020.03.014_bb0230","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1001\/jamaneurol.2016.6117","article-title":"Association of plasma neurofilament light with neurodegeneration in patients with Alzheimer disease","volume":"74","author":"Mattsson","year":"2017","journal-title":"JAMA Neurology"},{"key":"10.1016\/bs.irn.2020.03.014_bb0235","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1001\/jamaneurol.2019.0765","article-title":"Association between longitudinal plasma neurofilament light and neurodegeneration in patients with Alzheimer disease","volume":"76","author":"Mattsson","year":"2019","journal-title":"JAMA Neurology"},{"issue":"11","key":"10.1016\/bs.irn.2020.03.014_bb0240","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1001\/jamaneurol.2019.2214","article-title":"Staging \u03b2-amyloid pathology with amyloid positron emission tomography","volume":"76","author":"Mattsson","year":"2019","journal-title":"JAMA Neurology"},{"issue":"17","key":"10.1016\/bs.irn.2020.03.014_bb0245","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1212\/WNL.0000000000003246","article-title":"Plasma tau in Alzheimer disease","volume":"87","author":"Mattsson","year":"2016","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/bs.irn.2020.03.014_bb0250","doi-asserted-by":"crossref","first-page":"972","DOI":"10.2337\/dc18-1399","article-title":"Importance of treatment status in links between type 2 diabetes and Alzheimer's disease","volume":"42","author":"McIntosh","year":"2019","journal-title":"Diabetes Care"},{"issue":"8","key":"10.1016\/bs.irn.2020.03.014_bb0255","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.jalz.2018.02.013","article-title":"Plasma phospho-tau181 increases with Alzheimer's disease clinical severity and is associated with tau- and amyloid-positron emission tomography","volume":"14","author":"Mielke","year":"2018","journal-title":"Alzheimer's Dementia"},{"issue":"2","key":"10.1016\/bs.irn.2020.03.014_bb0260","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.neuron.2014.12.032","article-title":"Blood-brain barrier breakdown in the aging human hippocampus","volume":"85","author":"Montagne","year":"2015","journal-title":"Neuron"},{"issue":"13","key":"10.1016\/bs.irn.2020.03.014_bb0265","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1212\/WNL.0000000000001982","article-title":"Type 2 diabetes mellitus and biomarkers of neurodegeneration","volume":"85","author":"Moran","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/bs.irn.2020.03.014_bb0270","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/2051-5960-1-28","article-title":"Comparing metabolomic and pathologic biomarkers alone and in combination for discriminating Alzheimer's disease from normal cognitive aging","volume":"1","author":"Motsinger-Reif","year":"2013","journal-title":"Acta Neuropathologica Communications"},{"issue":"3","key":"10.1016\/bs.irn.2020.03.014_bb0275","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1159\/000105927","article-title":"Metabolic syndrome and dementia risk in a multiethnic elderly cohort","volume":"24","author":"Muller","year":"2007","journal-title":"Dementia and Geriatric Cognitive Disorders"},{"issue":"3","key":"10.1016\/bs.irn.2020.03.014_bb0280","doi-asserted-by":"crossref","first-page":"408","DOI":"10.2174\/18715273113126660156","article-title":"Diabetes of the brain: Computational approaches and interventional strategies","volume":"13","author":"Narasimhan","year":"2014","journal-title":"CNS & Neurological Disorders Drug Targets"},{"issue":"2","key":"10.1016\/bs.irn.2020.03.014_bb0285","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.jalz.2018.08.012","article-title":"Altered bile acid profile in mild cognitive impairment and Alzheimer's disease: Relationship to neuroimaging and CSF biomarkers","volume":"15","author":"Nho","year":"2019","journal-title":"Alzheimer's Dementia"},{"issue":"7","key":"10.1016\/bs.irn.2020.03.014_bb0290","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S1474-4422(16)00070-3","article-title":"CSF and blood biomarkers for the diagnosis of Alzheimer's disease: A systematic review and meta-analysis","volume":"15","author":"Olsson","year":"2016","journal-title":"The Lancet. Neurology"},{"issue":"19","key":"10.1016\/bs.irn.2020.03.014_bb0295","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1001\/jama.2015.4669","article-title":"Prevalence of amyloid PET positivity in dementia syndromes: A meta-analysis","volume":"313","author":"Ossenkoppele","year":"2015","journal-title":"JAMA"},{"issue":"12","key":"10.1016\/bs.irn.2020.03.014_bb0300","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201911170","article-title":"Cerebrospinal fluid and plasma biomarker trajectories with increasing amyloid deposition in Alzheimer's disease","volume":"11","author":"Palmqvist","year":"2019","journal-title":"EMBO Molecular Medicine"},{"key":"10.1016\/bs.irn.2020.03.014_bb0305","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1001\/jamaneurol.2019.1632","article-title":"Performance of fully automated plasma assays as screening tests for Alzheimer disease-related beta-amyloid status","volume":"76","author":"Palmqvist","year":"2019","journal-title":"JAMA Neurology"},{"issue":"3","key":"10.1016\/bs.irn.2020.03.014_bb0310","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1093\/brain\/awy347","article-title":"Plasma tau\/amyloid-beta1-42 ratio predicts brain tau deposition and neurodegeneration in Alzheimer's disease","volume":"142","author":"Park","year":"2019","journal-title":"Brain"},{"issue":"5","key":"10.1016\/bs.irn.2020.03.014_bb0315","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1001\/jamaneurol.2018.4666","article-title":"Assessment of plasma total tau level as a predictive biomarker for dementia and related endophenotypes","volume":"76","author":"Pase","year":"2019","journal-title":"JAMA Neurology"},{"issue":"4","key":"10.1016\/bs.irn.2020.03.014_bb0320","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.2337\/diabetes.51.4.1256","article-title":"Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: The Honolulu-Asia Aging Study","volume":"51","author":"Peila","year":"2002","journal-title":"Diabetes"},{"issue":"3","key":"10.1016\/bs.irn.2020.03.014_bb0325","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.3233\/JAD-161050","article-title":"Plasma amyloid-beta peptides in type 2 diabetes: A matched case-control study","volume":"56","author":"Peters","year":"2017","journal-title":"Journal of Alzheimer's Disease"},{"issue":"2","key":"10.1016\/bs.irn.2020.03.014_bb0330","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/s41591-018-0304-3","article-title":"Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer's disease","volume":"25","author":"Preische","year":"2019","journal-title":"Nature Medicine"},{"issue":"5","key":"10.1016\/bs.irn.2020.03.014_bb0335","doi-asserted-by":"crossref","first-page":"759","DOI":"10.2967\/jnumed.113.132647","article-title":"Diabetes and elevated hemoglobin A1c levels are associated with brain hypometabolism but not amyloid accumulation","volume":"55","author":"Roberts","year":"2014","journal-title":"Journal of Nuclear Medicine"},{"issue":"7","key":"10.1016\/bs.irn.2020.03.014_bb0340","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1093\/brain\/awy146","article-title":"Neurodegenerative disease concomitant proteinopathies are prevalent, age-related and APOE4-associated","volume":"141","author":"Robinson","year":"2018","journal-title":"Brain: A Journal of Neurology"},{"issue":"6","key":"10.1016\/bs.irn.2020.03.014_bb0345","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/j.neuron.2018.02.015","article-title":"Tau kinetics in neurons and the human central nervous system","volume":"97","author":"Sato","year":"2018","journal-title":"Neuron"},{"key":"10.1016\/bs.irn.2020.03.014_bb0350","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.mcn.2018.12.001","article-title":"Biomarkers for tau pathology","volume":"97","author":"Sch\u00f6ll","year":"2019","journal-title":"Molecular and Cellular Neurosciences"},{"key":"10.1016\/bs.irn.2020.03.014_bb0355","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.nicl.2016.05.017","article-title":"A large-scale comparison of cortical thickness and volume methods for measuring Alzheimer's disease severity","volume":"11","author":"Schwarz","year":"2016","journal-title":"NeuroImage. Clinical"},{"issue":"9","key":"10.1016\/bs.irn.2020.03.014_bb0360","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.1093\/brain\/awv181","article-title":"Cerebrospinal fluid tau and amyloid-\u03b21-42 in patients with dementia","volume":"138","author":"Skillb\u00e4ck","year":"2015","journal-title":"Brain"},{"issue":"3","key":"10.1016\/bs.irn.2020.03.014_bb0365","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002266","article-title":"Association between fatty acid metabolism in the brain and Alzheimer disease neuropathology and cognitive performance: A nontargeted metabolomic study","volume":"14","author":"Snowden","year":"2017","journal-title":"PLoS Medicine"},{"issue":"2","key":"10.1016\/bs.irn.2020.03.014_bb0370","doi-asserted-by":"crossref","first-page":"525","DOI":"10.3233\/JAD-150072","article-title":"Insulin resistance is associated with higher cerebrospinal fluid tau levels in asymptomatic APOEvarepsilon4 carriers","volume":"46","author":"Starks","year":"2015","journal-title":"Journal of Alzheimer's Disease"},{"issue":"9","key":"10.1016\/bs.irn.2020.03.014_bb0375","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1001\/jamaneurol.2013.284","article-title":"Glucose intolerance, insulin resistance, and pathological features of Alzheimer disease in the Baltimore Longitudinal Study of Aging","volume":"70","author":"Thambisetty","year":"2013","journal-title":"JAMA Neurology"},{"issue":"3","key":"10.1016\/bs.irn.2020.03.014_bb0380","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/s41591-020-0762-2","article-title":"Diagnostic value of plasma phosphorylated tau181 in Alzheimer's disease and frontotemporal lobar degeneration","volume":"26","author":"Thijssen","year":"2019","journal-title":"Nature Medicine"},{"issue":"9","key":"10.1016\/bs.irn.2020.03.014_bb0385","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.jalz.2017.01.020","article-title":"Metabolic network failures in Alzheimer's disease: A biochemical road map","volume":"13","author":"Toledo","year":"2017","journal-title":"Alzheimer's Dementia"},{"issue":"1","key":"10.1016\/bs.irn.2020.03.014_bb0390","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002482","article-title":"Brain and blood metabolite signatures of pathology and progression in Alzheimer disease: A targeted metabolomics study","volume":"15","author":"Varma","year":"2018","journal-title":"PLoS Medicine"},{"issue":"6","key":"10.1016\/bs.irn.2020.03.014_bb0395","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1001\/jamaneurol.2017.0244","article-title":"Evaluation of amyloid protective factors and Alzheimer disease neurodegeneration protective factors in elderly individuals","volume":"74","author":"Vemuri","year":"2017","journal-title":"JAMA Neurology"},{"issue":"5","key":"10.1016\/bs.irn.2020.03.014_bb0400","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1002\/ana.25334","article-title":"Plasma amyloid as prescreener for the earliest Alzheimer pathological changes","volume":"84","author":"Verberk","year":"2018","journal-title":"Annals of Neurology"},{"issue":"6","key":"10.1016\/bs.irn.2020.03.014_bb0405","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.jalz.2019.03.009","article-title":"Plasma amyloid beta 40\/42 ratio predicts cerebral amyloidosis in cognitively normal individuals at risk for Alzheimer's disease","volume":"15","author":"Vergallo","year":"2019","journal-title":"Alzheimer's Dementia"},{"issue":"1","key":"10.1016\/bs.irn.2020.03.014_bb0410","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.neulet.2011.09.049","article-title":"Alterations in the blood brain barrier in ageing cerebral cortex in relationship to Alzheimer-type pathology: A study in the MRC-CFAS population neuropathology cohort","volume":"505","author":"Viggars","year":"2011","journal-title":"Neuroscience Letters"},{"key":"10.1016\/bs.irn.2020.03.014_bb0415","article-title":"Cortical Microstructural alterations in mild cognitive impairment and Alzheimer's disease dementia","author":"Vogt","year":"2019","journal-title":"Cerebral Cortex"},{"issue":"1","key":"10.1016\/bs.irn.2020.03.014_bb0420","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13195-019-0472-5","article-title":"Longitudinal measurement of serum neurofilament light in presymptomatic familial Alzheimer's disease","volume":"11","author":"Weston","year":"2019","journal-title":"Alzheimer's Research & Therapy"},{"issue":"9","key":"10.1016\/bs.irn.2020.03.014_bb0425","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1001\/jamaneurol.2015.0613","article-title":"Association of insulin resistance with cerebral glucose uptake in late middle-aged adults at risk for Alzheimer disease","volume":"72","author":"Willette","year":"2015","journal-title":"JAMA Neurology"},{"issue":"5","key":"10.1016\/bs.irn.2020.03.014_bb0430","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.jalz.2014.03.011","article-title":"Insulin resistance predicts brain amyloid deposition in late middle-aged adults","volume":"11","author":"Willette","year":"2015","journal-title":"Alzheimer's Dementia"},{"issue":"12","key":"10.1016\/bs.irn.2020.03.014_bb0435","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0028263","article-title":"Hypoxia due to cardiac arrest induces a time-dependent increase in serum amyloid \u03b2 levels in humans","volume":"6","author":"Zetterberg","year":"2011","journal-title":"PLoS One"}],"container-title":["International Review of Neurobiology","Metabolic and Bioenergetic Drivers of Neurodegenerative Disease: Neurodegenerative Disease Research and Commonalities with Metabolic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0074774220300350?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0074774220300350?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T21:15:10Z","timestamp":1758748510000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0074774220300350"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"ISBN":["9780128200766"],"references-count":86,"URL":"https:\/\/doi.org\/10.1016\/bs.irn.2020.03.014","relation":{},"ISSN":["0074-7742"],"issn-type":[{"value":"0074-7742","type":"print"}],"subject":[],"published":{"date-parts":[[2020]]}}}